Pichia pastoris, with its advantages of high growth density, strong protein expression, good genetic stability, and mild glycosylation modification, has shown excellent application in both academic research and industrial production and has become the preferred Fungal Chassis cell for recombinant protein expression. With deep knowledge of synthetic biology and first-class biology technology, CD BioGlyco has constructed Chassis Cell Platforms for a wide range of applications and provides Pichia pastoris engineering services to clients all over the world and applying them to the Production process of glycobiomolecules.
To obtain efficiently Modified Chassis Strains, CD BioGlyco provides clients with precise and efficient gene editing techniques for homologous recombination of Pichia pastoris.
For example, knockdown of Ku70, a key gene for non-homologous end joining (NHEJ), overexpression of genes such as Rad52, which promotes homologous recombination (HR), and knockdown of the HR repressor gene Mph1. Among them, gene editing of Pichia pastoris using Ku70-deficient strains is also a common method for Pichia pastoris transformation.
Pichia pastoris, as a non-model yeast, is modified by CD BioGlyco using specifically expressed and modified genetic elements. Examples include promoters, screening markers based on nutrient-deficient genes and resistance genes, and methanol-induced, glycerol-induced, and glucose-induced induction.
To increase the production capacity of Pichia pastoris cell engineering, CD BioGlyco offers Pichia pastoris metabolic pathway modification services.
Introduction of heterologous enzymes to optimize the synthesis of natural metabolites
We modify the Pichia pastoris metabolic pathway by introducing exogenous genes into the Pichia pastoris cell via specific plasmids. For example, we enhance xylitol production by expressing heterologous D-arabinitol and xylitol dehydrogenase.
Integral knock-in of multiple heterologous genes to introduce new metabolic pathways
We use multi-gene one-step editing technology to realize the one-step import of key genes for target products. For example, we achieve efficient synthesis of alkaloids in Pichia pastoris by introducing dozens of exogenous genes.
Fig.1 Bioengineering of Pichia pastoris. (CD BioGlyco)
Technology: Modular cloning technology, homologous recombination, gene editing
Journal: Metabolic Engineering
IF: 8.4
Published: 2018
Results: Pichia pastoris can be efficiently modified by homologous recombination and CRISPR/Cas9 insertion, modification, or deletion of genes with the support of modular cloning technology. The modified Pichia pastoris can be applied to humanize protein glycosylation and improve the productivity of heterologous proteins.
CD BioGlyco customizes detailed and rigorous experimental procedures according to the scientific needs of our clients, and our various advanced technologies can fully meet their requirements. Please feel free to
if you would like to learn more about our services in fungal chassis cell engineering.Reference